Characteristics of nobiletin-mediated alteration of gene expression in cultured cell lines

Biochemical and Biophysical Research Communications

Volumn 431, Issue 3, 2013, Pages 530-534

  Nemoto, Kiyomitsu ^a   Ikeda, Ayaka ^a   Yoshida, Chiaki ^a   Kimura, Junko ^a   Mori, Junki ^a   Fujiwara, Hironori ^b   Yokosuka, Akihito ^c   Mimaki, Yoshihiro ^c   Ohizumi, Yasushi ^a,b,d   Degawa, Masakuni ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^d YOKOHAMA COLLEGE OF PHARMACY   (Japan)

Author keywords

Cell proliferation; Citrus peel; DNA microarray; Endoplasmic reticulum stress; Nobiletin; Oxidative stress

Indexed keywords

ASPARTATE AMMONIA LIGASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; NOBILETIN; THIOREDOXIN INTERACTING PROTEIN;

ANIMAL CELL; ARTICLE; ASNS GENE; CARCINOMA CELL; CCNA2 GENE; CCNE2 GENE; CELL CYCLE REGULATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DDIT3 GENE; DNA MICROARRAY; DOWN REGULATION; DRUG MECHANISM; E2F8 GENE; ENDOPLASMIC RETICULUM STRESS; FIBROBLAST; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRIB3 GENE; TXNIP GENE; UPREGULATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; FLAVONES; GENE EXPRESSION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS;

CITRUS; RATTUS;

EID: 84873722140     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.024     Document Type: Article

References (54)

1. Nagase H., Omae N., Omori A., et al. Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. Biochem. Biophys. Res. Commun. 2005, 337:1330-1336.
2. Matsuzaki K., Yamakuni T., Hashimoto M., et al. Nobiletin restoring β-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats. Neurosci. Lett. 2006, 400:230-234.
3. Nakajima A., Yamakuni T., Haraguchi M., et al. Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice. J. Pharmacol. Sci. 2007, 105:122-126.
4. Nakajima A., Yamakuni T., Matsuzaki K., et al. Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-d-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling. J. Pharmacol. Exp. Ther. 2007, 321:784-790.
5. Matsuzaki K., Miyazaki K., Sakai S., et al. Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus. Eur. J. Pharmacol. 2008, 578:194-200.
6. Onozuka H., Nakajima A., Matsuzaki K., et al. Nobiletin, a citrus flavonoid, improves memory impairment and Aβ pathology in a transgenic mouse model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 2008, 326:739-744.
7. Yamamoto Y., Shioda N., Han F., et al. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res. 2009, 1295:218-229.
8. Yi L.T., Xu H.L., Feng J., et al. Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin. Physiol. Behav. 2011, 102:1-6.
9. Murakami A., Nakamura Y., Torikai K., et al. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res. 2000, 60:5059-5066.
10. Sato T., Koike L., Miyata Y., et al. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Res. 2002, 62:1025-1029.
11. Zheng Q., Hirose Y., Yoshimi N., et al. Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells. J. Cancer Res. Clin. Oncol. 2002, 128:539-546.
12. 2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin. Mol. Cancer Ther. 2004, 3:839-847.
13. Ohnishi H., Asamoto M., Tujimura K., et al. Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Sci. 2004, 95:936-942.
14. Morley K.L., Ferguson P.J., Koropatnick J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett. 2007, 251:168-178.
15. Tang M., Ogawa K., Asamoto M., et al. Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci. 2007, 98:471-477.
16. Akao Y., Itoh T., Ohguchi K., et al. Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. Bioorg. Med. Chem. 2008, 16:2803-2810.
17. Luo G., Guan X., Zhou L. Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biol. Ther. 2008, 7:966-973.
18. Miyamoto S., Yasui Y., Tanaka T., et al. Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice. Carcinogenesis 2008, 29:1057-1063.
19. Miyata Y., Sato T., Imada K., et al. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochem. Biophys. Res. Commun. 2008, 366:168-173.
20. Kunimasa K., Ikekita M., Sato M., et al. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo. Cancer Sci. 2010, 101:2462-2469.
21. Miyamoto S., Yasui Y., Ohigashi H., et al. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. Chem. Biol. Interact. 2010, 183:276-283.
22. Lee Y.C., Cheng T.H., Lee J.S., et al. Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Mol. Cell. Biochem. 2011, 347:103-115.
23. Tang M.X., Ogawa K., Asamoto M., et al. Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats. Nutr. Cancer 2011, 63:227-233.
24. Saito T., Abe D., Sekiya K. Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2007, 357:371-376.
25. Kunimasa K., Kuranuki S., Matsuura N., et al. Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion. Bioorg. Med. Chem. Lett. 2009, 19:2062-2064.
26. Lee Y.S., Cha B.Y., Saito K., et al. Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Biochem. Pharmacol. 2010, 79:1674-1683.
27. Choi Y., Kim Y., Ham H., et al. Nobiletin suppresses adipogenesis by regulating the expression of adipogenic transcription factors and the activation of AMP-activated protein kinase (AMPK). J. Agric. Food Chem. 2011, 59:12843-12849.
28. Lin Y., Vermeer M.A., Bos W., et al. Molecular structures of citrus flavonoids determine their effects on lipid metabolism in HepG2 cells by primarily suppressing apoB secretion. J. Agric. Food Chem. 2011, 59:4496-4503.
29. Miyata Y., Tanaka H., Shimada A., et al. Regulation of adipocytokine secretion and adipocyte hypertrophy by polymethoxyflavonoids, nobiletin and tangeretin. Life Sci. 2011, 88:613-618.
30. Kanda K., Nishi K., Kadota A., et al. Nobiletin suppresses adipocyte differentiation of 3T3-L1 cells by an insulin and IBMX mixture induction. Biochim. Biophys. Acta. 1820, 2012:461-468.
31. Lin N., Sato T., Takayama Y., et al. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem. Pharmacol. 2003, 65:2065-2071.
32. Tanaka S., Sato T., Akimoto N., et al. Prevention of UVB-induced photoinflammation and photoaging by a polymethoxy flavonoid, nobiletin, in human keratinocytes in vivo and in vitro. Biochem. Pharmacol. 2004, 68:433-439.
33. Choi S.Y., Hwang J.H., Ko H.C., et al. Nobiletin from citrus fruit peel inhibits the DNA-binding activity of NF-κB and ROS production in LPS-activated RAW 264.7 cells. J. Ethnopharmacol. 2007, 113:149-155.
34. Choi S.Y., Ko H.C., Ko S.Y., et al. Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. Biol. Pharm. Bull. 2007, 30:772-778.
35. Hirata Y., Masuda Y., Kakutani H., et al. Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-κB, AP-1, and Sp1 activation. Biochem. Pharmacol. 2008, 75:1504-1514.
36. Nagase H., Yamakuni T., Matsuzaki K., et al. Mechanism of neurotrophic action of nobiletin in PC12D cells. Biochemistry 2005, 44:13683-13691.
37. Oyadomari S., Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004, 11:381-389.
38. Jakobsen C.H., Storvold G.L., Bremseth H., et al. DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis. J. Lipid Res. 2008, 49:2089-2100.
39. Tabas I., Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 2011, 13:184-190.
40. Watanabe R., Nakamura H., Masutani H., Yodoi J. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. Pharmacol. Ther. 2010, 127:261-270.
41. Zhou J., Yu Q., Chng W.J. TXNIP (VDUP-1, TBP-2): A major redox regulator commonly suppressed in cancer by epigenetic mechanisms. Int. J. Biochem. Cell Biol. 2011, 43:1668-1673.
42. Masutani H., Yoshihara E., Masaki S., Chen Z., Yodoi J. Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus. J. Clin. Biochem. Nutr. 2012, 50:23-34.
43. Chutkow W.A., Birkenfeld A.L., Brown J.D., et al. Deletion of the α-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity. Diabetes 2010, 59:1424-1434.
44. Perrone L., Sbai O., Nawroth P.P., Bierhaus A. The complexity of sporadic Alzheimer's disease pathogenesis: The role of RAGE as therapeutic target to promote neuroprotection by inhibiting neurovascular dysfunction. Int. J. Alzheimer's Dis. 2012, 2012:734956.
45. Oakley H., Cole S.L., Logan S., et al. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 2006, 26:10129-10140.
46. Zhou J., Chng W.J. Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. Mitochondrion 2013, in press, http://dx.doi.org/10.1016/j.mito.2012.06.004.
47. Sheth S.S., Bodnar J.S., Ghazalpour A., et al. Hepatocellular carcinoma in Txnip-deficient mice. Oncogene 2006, 25:3528-3536.
48. 3 up-regulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesis. J. Immunol. 2010, 185:3980-3989.
49. Nishizawa K., Nishiyama H., Matsui Y., et al. Thioredoxin-interacting protein suppresses bladder carcinogenesis. Carcinogenesis 2011, 32:1459-1466.
50. Kanehira M., Harada Y., Takata R., et al. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene 2007, 26:6448-6455.
51. Harada Y., Kanehira M., Fujisawa Y., et al. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. Cancer Res. 2010, 70:5829-5839.
52. Okayama H., Kohno T., Ishii Y., et al. Identification of genes up-regulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res. 2012, 72:100-111.
53. Deng Q., Wang Q., Zong W.Y., et al. E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation. Cancer Res. 2010, 70:782-791.
54. 1/S arrest. Genes Dev. 1994, 8:453-464.